# OnCo record enteropathy-associated-t-cell-lymphoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/enteropathy-associated-t-cell-lymphoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "enteropathy-associated-t-cell-lymphoma" ;
  schema:name "Enteropathy-associated T-cell lymphoma"@en ;
  schema:alternateName "EATL"@en, "Enteropathy-type T-cell lymphoma"@en, "Enteropathy-associated and hepatosplenic T-cell lymphoma"@en, "Coeliac-associated T-cell lymphoma"@en, "Type I EATL"@en ;
  schema:description "An aggressive T-cell lymphoma of the small bowel that arises out of coeliac disease, usually in somebody whose coeliac disease was diagnosed late or has not responded to a gluten-free diet. It often announces itself as a perforation or obstruction of the bowel in a person who is already underweight, which is why treatment has to deal with nutrition at the same time as the lymphoma."@en ;
  schema:url <https://onco.cc/cancers/enteropathy-associated-t-cell-lymphoma/> ;
  schema:dateModified "2026-09-29"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Enteropathy-associated_T-cell_lymphoma> ;
  schema:citation <https://doi.org/10.1038/s41375-022-01620-2>, <https://doi.org/10.1182/blood.2022015851>, <https://doi.org/10.1182/blood-2009-07-231324>, <https://doi.org/10.1038/bjc.2015.94>, <https://www.cancer.gov/types/lymphoma/hp/adult-nhl-treatment-pdq> ;
  onco:tag "heme", "lymphoma", "subtype-page" ;
  onco:related <https://onco.cc/cancers/monomorphic-epitheliotropic-intestinal-t-cell-lymphoma/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/cancers/hepatosplenic-t-cell-lymphoma/>, <https://onco.cc/cancers/small-bowel/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/technologies/fdg-pet/>, <https://onco.cc/technologies/autologous-stem-cell-transplant/> ;
  onco:drugs <https://onco.cc/drugs/ifosfamide/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/methotrexate/> ;
  onco:terms <https://onco.cc/terms/lymphoma-nodal-versus-extranodal/>, <https://onco.cc/terms/lymphoma-classification-2022/>, <https://onco.cc/terms/lymphoma-pit-score/>, <https://onco.cc/terms/lymphoma-tx-transplant-role/>, <https://onco.cc/terms/lymphoma-lugano-gastrointestinal/> ;
  onco:standardOfCare <https://onco.cc/terms/endoscopy/>, <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/terms/lymphoma-lugano-gastrointestinal/>, <https://onco.cc/technologies/fdg-pet/>, <https://onco.cc/terms/lymphoma-tx-regimen-alphabet/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/drugs/ifosfamide/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/technologies/autologous-stem-cell-transplant/>, <https://onco.cc/terms/lymphoma-tx-transplant-role/>, <https://onco.cc/terms/lymphoma-tx-regimen-alphabet/> .
